Transaction log

Feb 18, 2020 - Bought 10 @ $397.65 (3.98% wtg, coffee can)
Jun 10, 2020 - Sold 2 @ $611.80 (8 shares, 4.19% wtg)
Feb 8, 2021 - Bought 2 @ $497.62 (10 shares, 3.40% wtg)
Sep 7, 2023 - Sold 2 @ $820.09 (8 shares, 4.18% wtg)
Jul 1, 2024 - Sold 1 @ $1,067.86 (7 shares, 4.17% wtg)

Location: Tarrytown, New York

Estimated fair value history

Profile

Industry: Biotechnology

Sector: Health care

Theme: Genomic revolution

5-Year shareholder growth: +18.1%/year

Estimated fair value: $1,161

Valuation assumption: 20 x annual R&D

Insider ownership: 7.0%

Investments: Alnylam Pharmaceuticals (ALNY), Intellia Therapeutics (NTLA)

History

Jul 1, 2024

Raising cash

Jul 1, 2024

Latest craze: options that expire in one day. Time to raise cash. [trades]

Jul 1, 2024

Sep 7, 2023

Sep 7, 2023

We’re also initiating a position in Academy Sports + Outdoors. To make room, we’re trimming Regeneron Pharmaceuticals and Duluth Holdings. [trades]

Sep 7, 2023

Feb 8, 2021

Feb 8, 2021

Right now, gold stocks are on sale and stock prices high (putting it mildly). Adding to Regeneron. [trades]

Feb 8, 2021

Jun 10, 2020

Jun 10, 2020

"Never confuse brains with a bull market." That's exactly what Millennial traders are doing these days. [trades]

Jun 10, 2020

Feb 18, 2020

Feb 18, 2020

My coffee can pick here is Regeneron Pharmaceuticals (REGN), founded in 1988 by neurologist Len Schleifer…

Feb 18, 2020